Hermes Vector

Health

Ontario medical regulator pauses safer supply drug changes after legal challenge

The College of Physicians and Surgeons of Ontario is pausing enforcement of new safer supply prescription rules after being served with a legal challenge including an injunction motion.

By Hermes Vector

Also in: Español · Português · Français · Deutsch · हिन्दी · 中文

Checked against 2 sourcesthestar.comctvnews.ca
Illustration for: Ontario medical regulator pauses safer supply drug changes after legal challenge

In brief

  • The College of Physicians and Surgeons of Ontario was served Friday with a legal challenge including an injunction motion.
  • The regulator is pausing enforcement of new safer supply prescribing rules set to take effect Monday.
  • The rules would require safer supply drugs to be prescribed only with opioid agonist therapy and taken in front of health-care professionals.
  • The college says the changes aim to reduce opioids being diverted to the black market.

Ontario medical regulator pauses safer supply drug changes after legal challenge

Ontario’s medical regulator is pausing implementation of changes to how doctors prescribe safer supply drugs after it was served with a legal challenge.

Legal challenge and pause

The College of Physicians and Surgeons of Ontario says it was served Friday with the legal action, which includes a motion for an injunction to prevent the regulator from enforcing the new safer supply rules. The changes were set to come into effect on Monday, but the college says it is pausing enforcement to allow time to respond to the injunction.

The new rules

The college approved sweeping changes to the safer supply prescription regime last month that would require doctors to prescribe safer supply drugs only in conjunction with opioid agonist therapy. Safer supply drugs are medications given to people at high risk of overdose as an alternative to illicit opioids, while opioid agonist therapy uses medications such as Suboxone and methadone to treat opioid addiction.

The new rules would also require patients to take their safer supply medications in front of health-care professionals, rather than take them home — a change that has raised accessibility concerns especially for patients in rural Ontario and those who work regular hours.

Regulator’s stated rationale

The medical regulator has said the changes were approved in an effort to reduce the amount of opioids prescribed as safer supply drugs making their way to the streets. The chair of the regulator’s board, Dr. Patrick Safieh, has said police forces in Ontario are noticing patients’ safer supply drugs being diverted to the black market.

Why it matters

The pause means the new prescribing rules will not be enforced on Monday as planned, leaving the current safer supply framework in place while the legal challenge proceeds.


Sources

This article was drafted with AI assistance and checked against the sources above. Company claims are reported as claims. Cover image is AI-generated.

Questions readers ask

Who is pausing the implementation of the new safer supply drug rules?
The College of Physicians and Surgeons of Ontario is pausing the implementation of the changes after being served with a legal challenge.
When were the new rules originally set to come into effect?
The changes were set to come into effect on Monday.
What are the key changes to the safer supply prescription regime?
The new rules require doctors to prescribe safer supply drugs only in conjunction with opioid agonist therapy and mandate that patients take their medications in front of health-care professionals rather than taking them home.
Why did the regulator approve the changes to the safer supply rules?
The regulator stated the changes were approved to reduce the amount of opioids prescribed as safer supply drugs making their way to the streets, citing reports from police forces about diversion to the black market.
Who is the chair of the regulator’s board mentioned in the article?
Dr. Patrick Safieh is the chair of the regulator’s board.

The day's checked news, by email

One short email a day with the top stories. Free, and you can unsubscribe in one click.

Or follow for the latest news:

How do you feel about this story?

Comments 0

No comments yet. Start the discussion.

Health

US measles elimination status under review by PAHO panel

A panel of independent experts convened by the Pan American Health Organization has ruled that the United States no longer meets the criteria for measles elimination, according to reports citing anonymous sources. The PAHO director must still rule on the recommendation.

Checked against 3 sourcesctvnews.catoday.rtl.lueastleighvoice.co.ke